Skip to content

Stimulation Therapy in Military Veterans

Stimulation Therapy in Military Veterans - STIM

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON46862
Enrollment
96
Registered
2016-04-25
Start date
2016-06-21
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post-traumatic stress disorder

Interventions

TDCS (1.25 mA, 20 min.) increases neural excitability under the anodal electrode (here: attached to the scalp over the right inferior frontal gyrus, rIFG) and decreases neural excitability under the

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Dutch military personnel - Age 18 - 60 years - Presence of problems with aggression regulation according to criteria as described in (Coccaro, 2012) or any anxiety disorder according to DSM-IV criteria except for obsessive-compulsive disorder (OCD) - Receive treatment for above-mentioned symptoms - Provide written informed consent

Exclusion criteria

Exclusion criteria: - Predominant major depressive disorder (MDD) - Alcohol or drug dependence - Severe psychiatric or neurological disorders, e.g., Parkinson*s disease. - Serious head trauma or brain surgery (N.B. TBI without brain damage or skull damage is not a reason for exclusion) - Large or ferromagnetic metal parts in the head (except for a dental wire) - Implanted cardiac pacemaker or neurostimulator - Pregnancy - Concurrent or recent (within previous month) participation in a neuromodulation / neurostimulation (e.g., tDCS, TMS) experiment. - Skin damage or diseases at intended electrode sites (tDCS)

Design outcomes

Primary

MeasureTime frame
The main study parameter is the pre-to post-intervention change in inhibitory control on the training task (stop-signal task).

Secondary

MeasureTime frame
Second, we aim to test the pre-to post-intervention changes in symptoms related to anxiety and aggression, threat-related (emotional Go/No-Go task) and implicit inhibitory control (implicit association task). Additionally we look at post-intervention attentional threat avoidance (dot-probe task). Finally, we assess symptom reduction at 3 and 12 months follow-up.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)